Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

NCT07123038 is registered in ClinicalTrials.gov with Sonoma Biotherapeutics, Inc. as lead sponsor.

NCT NCT07123038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07123038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
Lead sponsor
Sonoma Biotherapeutics, Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 22, 2025
Completion date
December 31, 2040
Enrollment
36 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa (hs), rheumatoid arthritis (ra)